Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder
Abstract There are currently five programmed death-1 (PD-1)/programmed death ligand-1 (PD-L1) inhibitors approved for the treatment of locally advanced or metastatic urothelial carcinoma (UC) of the bladder. For platinum-ineligible patients, testing of tumor specimens for PD-L1 expression is require...
Enregistré dans:
Auteurs principaux: | Georgi Tosev, Wasilijiang Wahafu, Philipp Reimold, Ivan Damgov, Constantin Schwab, Cem Aksoy, Adam Kaczorowski, Albrecht Stenzinger, Joanne Nyarangi-Dix, Markus Hohenfellner, Stefan Duensing |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/e0963328ed3e40d1b1cbaada103b02e7 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Publisher Correction: Detection of PD-L1 in the urine of patients with urothelial carcinoma of the bladder
par: Georgi Tosev, et autres
Publié: (2021) -
Expression of Spred2 in the urothelial tumorigenesis of the urinary bladder.
par: Shinsuke Oda, et autres
Publié: (2021) -
Gold nanoparticles as physiological markers of urine internalization into urothelial cells in vivo
par: Hudoklin S, et autres
Publié: (2013) -
Autocrine signaling by receptor tyrosine kinases in urothelial carcinoma of the bladder.
par: Young H Lee, et autres
Publié: (2021) -
Bladder Recurrence Following the Treatment of Upper Tract Urothelial Carcinoma
par: Takarn Itsaranujareankul, et autres
Publié: (2021)